Trial Profile
A prospective, randomized, multi-center comparison of the cypher sirolimus-eluting and the taxus paclitaxel-eluting stent systems
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Paclitaxel
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms REALITY
- Sponsors Cordis Corporation
- 04 Jul 2007 New trial record.